Endometriosis and Glanzmanns thrombasthenia
L Imperiale1, L Manganaro2, A Ticino1
1Department of Gynecology, Obstetrics and Urology, Sapienza, University of Rome, Policlinico Umberto I, Rome, Italy.
Journal of Biological Regulators and Homeostatic Agents
|September 23, 2016
Summary
Glanzmann's thrombasthenia (GT), a rare bleeding disorder, may increase the risk of developing endometriosis. Managing these co-occurring conditions presents unique challenges, particularly concerning surgical interventions and bleeding risks.
Area of Science:
- Hematology
- Gynecology
- Reproductive Medicine
Background:
- Glanzmann's thrombasthenia (GT) is a rare inherited bleeding disorder affecting platelet aggregation.
- Endometriosis, a condition involving endometrial tissue outside the uterus, is hypothesized to be linked to retrograde menstruation.
- The potential predisposition of GT to endometriosis remains an area of investigation.
Observation:
- This study reports on three sisters diagnosed with both endometriosis and Glanzmann's thrombasthenia.
- The patients presented with varying clinical manifestations and received distinct therapeutic approaches.
- Management strategies were tailored considering the complexities of co-existing GT and endometriosis.
Findings:
- The cases highlight the intricate relationship between bleeding disorders and gynecological conditions.
- Different treatment modalities were employed, showcasing the need for individualized patient care.
- Surgical interventions in patients with GT require careful planning to mitigate bleeding risks.
Implications:
- Understanding the GT-endometriosis link can improve diagnostic and management protocols.
- This case series underscores the importance of multidisciplinary care for patients with rare bleeding disorders and gynecological conditions.
- Further research is warranted to elucidate the underlying mechanisms and optimize therapeutic outcomes.
Related Concept Videos
Disorders of Hemostasis
2.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K
Glucose Transporters
28.0K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Venous Thrombosis I: Introduction
622
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
622
Gastritis-I: Introduction and Types
3.1K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
3.1K
Proteoglycans
5.1K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
5.1K


